Understanding how variation in clinical practice affects length of stay for patients with malignant pleural effusion.

C. Tan (Singapore, Singapore), P. Quek (Singapore, Singapore), R. Chang (Singapore, Singapore)

Source: International Congress 2019 – Pleural disease: applying the evidence
Session: Pleural disease: applying the evidence
Session type: Thematic Poster
Number: 3093
Disease area: Thoracic oncology

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
C. Tan (Singapore, Singapore), P. Quek (Singapore, Singapore), R. Chang (Singapore, Singapore). Understanding how variation in clinical practice affects length of stay for patients with malignant pleural effusion.. 3093

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Pleural effusions in medical ICU –prevalence, causes and clinical significance
Source: Annual Congress 2009 - Pleural and parenchymal diseases
Year: 2009


The effect of a pleural diseases clinic on pleural effusion admission rates
Source: Annual Congress 2012 - Diagnosis and biology of malignant pleural effusions
Year: 2012


Is the size of pleural effusion important in the study of patients whose first tumor manifestation is a pleural effusion?
Source: International Congress 2017 – Pleural and mediastinal malignancies
Year: 2017


Correlation of accompanying pleural effusion with patient characteristics and mortality in patients with community acquired pneumonia
Source: Annual Congress 2007 - Community-acquired pneumonia: from aetiology to complication
Year: 2007


The referral to diagnosis time for patients with malignant effusions presenting to a respiratory pleural clinic
Source: Annual Congress 2010 - Current issues in malignant pleural diseases
Year: 2010


Impact of sarcopenia in long-term symptoms in patients with malignant pleural effusion.
Source: Virtual Congress 2021 – Accurate diagnosis and prediction of malignant pleural disease
Year: 2021


How often is a single therapeutic aspiration sufficient to manage a malignant pleural effusion and does oncological treatment have an impact on this?
Source: International Congress 2019 – Pleural disease: applying the evidence
Year: 2019

Optimal management of symptomatic malignant pleural effusions: individualised care
Source: Virtual Congress 2021 – Hot news from the pleura
Year: 2021


Initial management of pleural effusions: an audit of our practice – could we do better to improve patient care and reduce length of stay?
Source: Annual Congress 2009 - Pleural and mediastinal diseases
Year: 2009

Are patients with malignant pleural effusions being referred appropriately for surgical intervention?
Source: Annual Congress 2008 - Management, quality aspects and prognosis in thoracic oncology
Year: 2008


Impact of indwelling pleural catheter on quality of life in management of malignant pleural effusion in patients with advanced malignancies
Source: Annual Congress 2012 - Biology and treatment of malignant pleural effusions
Year: 2012



Predictors of survival in patients with recurrent malignant pleural effusion
Source: Annual Congress 2008 - Diagnostic and therapeutic approaches in pleural diseases
Year: 2008


Influence of psychological distress on symptom burden of patients admitted by malignant pleural effusion
Source: Virtual Congress 2020 – Novel directions in pleural disease: bench to bedside
Year: 2020


Lent score and informed management decisions in malignant pleural effusions (MPE). When is little too much?
Source: International Congress 2019 – Symptoms, risks, complications and palliative care in thoracic oncology
Year: 2019

A complex course in a pleural mesothelioma patient
Source: International Congress 2019 – Lung cancer Grand Round
Year: 2019


Histology, performance status and lymphopenia are factors of survival in patients undergoing thoracoscopy for malignant pleural effusion
Source: Annual Congress 2009 - Trends in bronchoscopy
Year: 2009


The role of CTPA in investigating a patient with a pleural effusion of unknown etiology
Source: Virtual Congress 2021 – Clinical problems associated with cough, pleura and respiratory health status
Year: 2021

Determination of the extent of pleural effusion: factors influencing clinical assessment
Source: Eur Respir J 2004; 24: Suppl. 48, 538s
Year: 2004

A 10-year experience of pleurodesis for malignant pleural effusion in a district general hospital
Source: Annual Congress 2010 - Treatment of lung cancer
Year: 2010

Effect of hospital volume on patient outcomes in pleural infection
Source: Annual Congress 2012 - Epidemiology of various respiratory diseases
Year: 2012